Integer (ITGR) vs. Its Rivals Head to Head Review

Integer (NYSE:ITGR) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare Integer to similar companies based on the strength of its dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Valuation & Earnings

This table compares Integer and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Integer	$1.83 billion	$102.81 million	42.48
Integer Competitors	$1.89 billion	$138.79 million	10.34

Integer’s rivals have higher revenue and earnings than Integer. Integer is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Integer and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Integer	5.68%	11.84%	5.98%
Integer Competitors	-305.24%	-170.58%	-22.05%

Risk & Volatility

Integer has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Integer’s rivals have a beta of 2.55, suggesting that their average share price is 155% more volatile than the S&P 500.

Insider & Institutional Ownership

99.3% of Integer shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings for Integer and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0	11	1	0	2.08
Integer Competitors	4279	10550	18327	829	2.46

Integer presently has a consensus target price of $113.67, suggesting a potential downside of 10.21%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.79%. Given Integer’s rivals stronger consensus rating and higher probable upside, analysts plainly believe Integer has less favorable growth aspects than its rivals.

Summary

Integer rivals beat Integer on 8 of the 13 factors compared.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.